Skip Nav Destination
First Edition
Research Article October 29 2025
The XPO7-NPAT axis represents key vulnerabilities in TP53-mutated acute myeloid leukemia
Research Article October 29 2025
Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 Cohort 3
Tom van Meerten,Marie José Kersten,Gloria Iacoboni,Georg R. Hess,Pim G.N.J. Mutsaers,Alejandro Martin Martin Garcia-Sancho,Andre Goy,Eva Gine,Brian T. Hill,Wen-Kai Weng,Patrick M. Reagan,Krish Patel,Ahmed Galal,Charles Herbaux,Robin Sanderson,Edouard Forcade,Max S. Topp,Roch Houot,Dan Zheng,Wangshu Zhang,Justyna Kanska,Rhine R Shen,Rita Damico Khalid,Ioana Kloos,Martin Dreyling,Michael L Wang
Letter October 29 2025
High-grade/large B-cell lymphoma-11q has a very good prognosis in children and young people without a predisposition
Leila Ronceray,Minke Henrina Willemina Huibers,Katrin Reutter,Oussama Abla,Mara Andres,Olga Balagué,Monika Csoka,Gil Gilad,Melanie M Hagleitner,Daiki Hori,Lisa Lyngsie Hjalgrim,Janez Jazbec,Wolfram Klapper,Atsuko Nakazawa,Jaime Verdu-Amorós,Hannah von Mersi,Wilhelm Woessmann,Ana C Xavier,Birgit Burkhardt,Itziar Salaverria,Andishe Attarbaschi
Research Article October 27 2025
Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML
Viktor Fetsch,Lennard Frederik Schwöbel,Ezgi Ozyerli-Goknar, PhD,Anna-Verena Stell,Marco Punta,Thomas Plenge,Tabea Klaus,Manoj K. Gupta,Geoffroy Andrieux,Khalid Shoumariyeh,Sophie Pfeiffer,Eyleen Corrales,Lina Schlenke,Hosna Baniadam,Simon M. Brandl,Massimo Andreis,Michal Remen,Alina Hartmann,Kathleen Grueter,Melissa Zwick,Natalie Köhler,Monika Kuban,Eric Metzger,Christoph Rummelt,Justus Duyster,Melanie Börries,Maike Hofmann,Julian Färber,Lukas M Braun,Alexander Zähringer,Michael Lübbert,Cristina Toffalori,Luca Vago,Florian H Heidel,Susana Minguet,Petya Apostolova,Tobias Feuchtinger,Kristina Maas-Bauer,Franziska Blaeschke,Michael W.M. Kühn,Marc Timmers,Tobias Wertheimer,Florian Perner,Robert Zeiser
Research Article October 27 2025
Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AML
Bogdan Popescu,Matthew F Jones,Madison Piao,Elaine Tran,Andrew Koh,Isabelle Lomeli,Cheryl A. C. Peretz,Natalia Murad,Sydney Abelson,Carolina E. Morales,Jose M Rivera,Alexa Rane Batingana,Jeevitha D'Souza,Yana Pikman,Michael L. Cheng,Aaron C Logan,Benjamin J. Huang,Elliot Stieglitz,Catherine C. Smith
Research Article October 24 2025
Age‐adapted chemotherapy and MRD‐oriented transplant for Ph-negative acute lymphoblastic leukemia: the GRAALL-2014 trial
Nicolas Boissel,Sylvie Chevret,Françoise Rigal-Huguet,Thibaut TL Leguay,Mathilde Hunault,Carlos Graux,Yves Chalandon,Eric Delabesse,Yosr Hicheri,Patrice Chevallier,Marie Balsat,Cedric Pastoret,Martine Escoffre-Barbe,Florence Pasquier,Magalie Joris,Anne Thiebaut,Anne Huynh,Nathalie Dhedin,Emilie Lemasle,Caroline Bonmati,Sebastien Maury,Gaelle Guillerm,Ana Berceanu,Urs Schanz,Thomas Cluzeau,Pascal Turlure,Philippe Rousselot,Bernard De Prijck,Nathalie Grardel,Marie-Christine Béné,Marina Lafage-Pochitaloff,Wendy Cuccuini,Norbert H Ifrah,Véronique Lheritier,Vahid Asnafi,Emmanuelle Clappier,Hervé Dombret
Research Article October 23 2025
Therapeutic base editing to generate a gain-of-function F9 variant for hemophilia B
Brief Report October 21 2025
Fully Human anti-GPRC5D CAR T-Cell Therapy RD118 Induces Durable Remissions in Relapsed/Refractory Multiple Myeloma
Research Article October 21 2025
CPX-351 in Down syndrome-associated Myeloid Leukemia: Results and Prognostic Factors from the Phase 3 ML-DS 2018 Trial
Stephanie Laszig,Antonia Diederichs,Emilia Salzmann-Manrique,Konstantin Schuschel,José Goncalves-Dias,Hasan Issa,Milica Miladinovic,Eva Rettinger,Sibylle Wehner,Hermann Kreyenberg,Melanie Bremm,Sabine Hünecke,Helena Kerp,Katharina Waack-Buchholz,Felicitas R Thol,Bianca F Goemans,Barbara De Moerloose,Heidrun Boztug,Nastassja Keora Scheidegger,Katarzyna Pawinska-Wasikowska,Dirk Reinhardt,Jan-Henning Klusmann
Research Article October 20 2025
The Proteostasis Network is a Therapeutic Target in Acute Myeloid Leukemia
Review Article October 17 2025
Diagnosis and Management of AML in Pediatric Patients: Consensus Recommendations from an International Expert Panel
C. Michel Zwaan,Sarah K Tasian,Richard Aplenc,Lisa Eidenschink Brodersen,Barbara Buldini,Barbara De Moerloose,Michael N Dworzak,Linda Fogelstrand,Brenda ES Gibson,Bianca F Goemans,Henrik Hasle,Betsy A Hirsch,Gertjan JL Kaspers,Jan-Henning Klusmann,Matthew A Kutny,Thomas Lehrnbecher,Franco Locatelli,Shoeil Meshinchi,Arnaud Petit,Martina Pigazzi,Anne Tierens,E Anders Kolb,Dirk Reinhardt,Daisuke Tomizawa,Todd M Cooper
Research Article October 16 2025
A CD22-Specific T-Cell Receptor Enables Effective Adoptive T-Cell Therapy for B-cell malignancies
Simone Rhein,Neşe Çakmak-Görür,Corinna Grunert,Sarah Hayder Jalal Al-Tabatabaee,Nazli Serin,Matthias Leisegang,Stefanos Timiliotis,Luisa Sophie Ohlmeier,Cäcilia Freund,Gerald Willimsky,Frank Konietschke,Elisa Kieback,Sarah K Tasian,Bjoern Chapuy,Ulrich Keller,Thomas Blankenstein,Antonio Pezzutto,Antonia Busse
Research Article October 16 2025
Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma models
Research Article October 16 2025
Impact of Modernizing Eligibility Criteria on Enrollment and Representation in Acute Myeloid Leukemia Clinical Trials
Andrew Hantel,Yating Wang,Angel Cronin,Irum Khan,Ivy Elizabeth Abraham,Ann-Kathrin Eisfeld,Anand A Patel,Wendy A Stock,Sarah Monick,Thomas P Walsh,Erin Gallagher,Marlise R. Luskin,Ana Maria Avila Rodriguez,Carlos Galvez,Peter G. Doukas,Jessica K Altman,Madelyn Burkart,Amani Erra,Maryam Zia,Melissa L. Larson,Ami Dave,Stephanie B. Tsai,Ahmed Aleem,Nepheli Ioanna Raptis,Christopher S Lathan,Hajime Uno,Daniel J. DeAngelo,Gregory A. Abel
Research Article October 10 2025
Challenging the Concept of Functional High-Risk Myeloma through Transcriptional and Genetic Profiling
Research Article October 8 2025
Distinct Biological Subtypes of Chronic GVHD after Pediatric Hematopoietic Cell Transplantation
Bernard Ng,Andrew C. Harris,Sayeh Abdossamadi,Geraldine Aubert,Rajinder P. Bajwa,Monica Bhatia,Henrique Bittencourt,Nataliya Prokopenko Buxbaum,Emi H. Caywood,Sonali Chaudhury,Joseph H Chewning,Sung Won Choi,Ashley Chopek,Julia Chu,Donald Coulter,Shahinaz M Gadalla,Richard T Hogg,David A Jacobsohn,Amanda K Johnson,Michael Joyce,Kimberly A. Kasow,Michael Kent,Carrie L. Kitko,Donna Lau,Anita Lawitschka,Victor Anthony Lewis,Amanda M Li,Laura Michelle McLaughlin,David Mitchell,Eneida R. Nemecek,Vaishnavi Parthasarathy,Anna B Pawlowska,Filip Pirsl,Michael A. Pulsipher,Muna Qayed,Jacob Rozmus,Süreyya Savaşan,Tal Schechter,Shalini Shenoy,Alima Suleimenova,Dong Jun Zheng,Elena Ostroumov,Andrew Gilman,Ramon I Klein Geltink,Daniel Wolff,Geoffrey D.E. Cuvelier,Kirk R. Schultz
Research Article October 8 2025
Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone
Luca Bertamini,Cathelijne Fokkema,Paula Rodriguez-Otero,Mark van Duin,Evangelos Terpos,Mattia D'Agostino,Vincent H.J. van der Velden,Niels W.C.J. van de Donk,Michel Delforge,Christoph Driessen,Roman Hajek,Hermann Einsele,Annette Juul Vangsted,Diego Vieyra,Ricardo M Attar,Anna Sitthi-Amorn,Robin Carson,Fredrik Schjesvold,Pawel Robak,Meral Beksac,Andrew Spencer,Annemiek Broijl,Tom Cupedo,Philippe Moreau,Mario Boccadoro,Pieter Sonneveld
Research Article October 8 2025
Phase 2 trial of rituximab with either pentostatin or bendamustine for multiply relapsed or refractory hairy cell leukemia
Research Article October 8 2025
Inflammation perturbs hematopoiesis by remodeling specific compartments of the bone marrow niche
Brief Report October 8 2025
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia
Dorien Pastoors,Marije Havermans,Roger Mulet-Lazaro,Leonie Smeenk,Sophie Ottema,Claudia A.J. Erpelinck-Verschueren,Stanley van Herk,Maikel Anthonissen,Tim Grob,Shruthi Subramanian,Julie A I Thoms,John E Pimanda,Bas J Wouters,Berna H Beverloo,Torsten Haferlach,Claudia Haferlach,Johannes Zuber,Eric Bindels,Ruud Delwel
Research Article October 7 2025
Genomic Determinants of Response and Resistance to Pirtobrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia
Jennifer R. Brown,Bastien Nguyen,Sai Prasad Desikan,Helen Won,Shady I. Tantawy,Samuel C McNeely,Narasimha Marella,Hetal S Randeria,Lauren M Hanson,Andrew Parker,Salome Calado Botelho,Jennifer A. Woyach,Krish Patel,Constantine S Tam,Toby A. Eyre,Chan Y Cheah,Nirav N Shah,Paolo Ghia,Wojciech Jurczak,Minna Balbas,Binoj Chandrasekharan Nair,Paolo B. Abada,Chunxiao Wang,Denise Wang,Lindsey Elizabeth Roeker,Varsha Gandhi,William G. Wierda
Research Article October 7 2025
A Notch trans-activation to cis-inhibition switch underlies hematopoietic stem cell aging
Research Article October 1 2025
Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation
Ekin Ece Gurer Kluge,Elisabeth Meedt,Julia Feicht,Kedi Cao,Andreas Hiergeist,Andreas Mamilos,Daniela Hirsch,Matthias Hoepting, Dr. med,Anna-Sophia Kattner, Dr. med,Carina Matos,Sigrid Bülow,Erik Thiele Orberg,Philipp Beckhove,Arne Kandulski,Matthias Evert,Kai Hildner,Marina Kreutz,Matthias Edinger,Daniel Wolff,Wolfgang Herr,Hendrik Poeck,André Gessner,Daniela Andrea Weber,Birte Kehr,Ernst Holler, Prof. Dr. med,Sakhila Ghimire
Research Article October 1 2025
Fetal context conveys heritable protection against MLL-rearranged AML that depends on MLL3
Brief Report September 30 2025
Genome-wide analysis defines genetic determinants of MPN subtypes and identifies a sex-specific association at CDH22/CD40
William J Tapper,Ahmed A.Z. Dawoud,Joannah Score,Andrew J Chase,E. Joanna Baxter,Joanne Ewing,Louise Wallis,Paola Guglielmelli,Dolors Colomer,Beatriz Bellosillo,Monste Gomez,Juan Carlos Hernandez-Boluda,Carlos Besses,Francisco Cervantes,Steffen Koschmieder,Anthony R Green,Andreas Reiter,Alessandro M. Vannucchi,Claire N. Harrison,Nicholas C.P. Cross
Research Article September 30 2025
Mechanisms of immune escape and extramedullary tropism in leukemia cutis
Research Article September 25 2025
Interplay of procoagulatory and neutrophil-derived anticoagulatory proteins in C1q-NET-driven blood coagulation
Research Article September 25 2025
PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study
Carrie Thompson,Marek Trněný,Franck Morschhauser,Gilles A. Salles,Patrick M. M. Reagan,Mark Hertzberg,Huilai Zhang,Catherine Thieblemont,Bei Hu,Gustavo Fonseca,Won Seog Seog Kim,Maurizio Martelli,Amitkumar Mehta,Avrita Singh,Mark Yan,Jamie Hirata,Matthew Sugidono,Calvin Lee, MD,Jeff P. Sharman,Neha Mehta-Shah,Christopher R. Flowers,Hervé Tilly,Neil Chua,Olivier Casasnovas,Fiona Miall,Tae Min Min Kim,Xavier Cheng-Hong Tsai,Sunita D. Nasta,Seung Tae Lee,Jonathan W. Friedberg
Research Article September 25 2025
Genomic landscape of IgM-MGUS and patients with stable or progressive asymptomatic Waldenström macroglobulinemia
Tina Bagratuni, Dr,Ourania Theologi,Christos Vlachos, Dr,Ioannis Kollias,Kylee H. Maclachlan,Foteini Aktypi,Nefeli Mavrianou-Koutsoukou,Christine I Liacos,Konstantina Taouxi,Alexandra Papadimou,Katerina Chrisostomidou,Maria Sakkou,Irene Solia,Foteini Theodorakou,Gianmarco Favrin,Maria Gavriatopoulou,Evangelos Terpos,Marzia Varettoni,Zachary R Hunter,Steven P. Treon,Francesco Maura,Meletios-Athanasios Athanasios Dimopoulos,Efstathios Kastritis
Research Article September 24 2025
CEBPA repression by MECOM blocks differentiation to drive aggressive leukemias
Travis Fleming,Mateusz Antoszewski,Sander Lambo,Michael Gundry,Riccardo Piussi,Lara Wahlster,Sanjana B. Shah,Fiona Reed,Kevin Dong,Joao A Paulo,Steven Gygi,Claudia A Mimoso,Seth Goldman,Karen Adelman,Jennifer A. Perry,Yana Pikman,Kimberly Stegmaier,Maria N Barrachina,Kellie R Machlus,Volker Hovestadt,Andrea Arruda,Mark D Minden,Richard A Voit,Vijay G Sankaran
Research Article September 24 2025
High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing
Anaïs Schavgoulidze,Aurore Perrot,Xavier Leleu,Titouan Cazaubiel,Marie-Lorraine Chretien,Pierre Feugier,Karim Belhadj,Salomon Manier,Murielle Roussel,Sabine Brechignac,Frederique Orsini Piocelle,Mohamad Mohty,Jean Marc Schiano de Colella,Margaret Macro, Dr,Didier Adiko,Mamoun Dib,Jean Fontan,Carine Motard,Didier Bouscary,Laurent Pascal,Virginie Roland,Francois Lifermann,Jana Armelle Bakala,Lydia Montes,Celine Kennel,Philippe Rey,Valentine Richez,Faiza Keddar,Laurent Frenzel,Claire Calmettes,Carine Chaleteix,Isabelle Plantier,Emilie Chalayer,Anna Schmitt,Christophe Roul,Hélène Demarquette,Chloe Cerutti,Luka Pavageau,Laure Derrier,Hervé Avet-Loiseau,Jill Corre
Research Article September 24 2025
Fusion Gene Depletion Eliminates Stemness and Induces Bidirectional Differentiation of Acute Myeloid Leukemia
Research Article September 24 2025
Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial
Françoise Kraeber-Bodere,Bastien Jamet,Sonja Zweegman,Aurore Perrot,Cyrille Hulin,Denis Caillot,Thierry Facon,Xavier Leleu,Karim Belhadj,Emmanuel Itti,Lionel Karlin,Clement Bailly,Mark-David Levin,Monique C. Minnema,Caroline Bodet-Milin,Bart de Keizer,Jill Corre,Pieter Sonneveld,Philippe Moreau,Thomas Carlier,Cyrille Touzeau
Research Article September 22 2025
Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapy
Mark B Meads,Xiaohong Zhao,David R Noyes,Praneeth Sudalagunta,Alexandra Achille,Chaomei Zhang,Rafael Renatino Canevarolo,Maria Silva,Dario Magaletti,Danny DeAvila,Sonila Toska,Ashley Oates,Daniel Lastorino,Dietrich Werner Idiaquez,Jinming Song,Samer Sansil,Sean J Yoder,Ariel F Grajales-Cruz,Brandon J Blue,Ciara L Freeman,Jongphil Kim,Melissa Alsina,Jason Brayer,Ariosto Siqueira Silva,Xiaofei Song,Kenneth H Shain,Rachid C Baz
Research Article September 22 2025
INCREASED LEF1 PROTEIN LEVELS AND ISOFORM SWITCHING DRIVE CELL PROLIFERATION IN CHRONIC LYMPHOCYTIC LEUKEMIA
Judith Mateos-Jaimez,Anna Vidal Crespo,Stella Charalampopoulou,Raul Fernandez Perez,Vicente Chapaprieta,Víctor Jiménez-Martínez,Liska Caviedes-Cárdenas,Martí Duran-Ferrer,Guadalupe Espadas,Eduard Sabido,Anne Largeot,Sophie A. Herbst,Sascha Dietrich,Miguel Bastos Boente,Miguel Alcoceba,Ferran Nadeu,Ingo Ringshausen,Jerome Paggetti,Etienne Moussay,Dolors Colomer,Elías Campo,Alba Maiques-Diaz,Jose Ignacio Martin-Subero
Research Article September 22 2025
Alternative AAV gene therapy for hemophilia A using expression of Bi8, a novel single-chain FVIII-mimetic antibody
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals